Form 8-K - Current report:
SEC Accession No. 0001193125-25-122821
Filing Date
2025-05-20
Accepted
2025-05-20 07:16:44
Documents
30
Period of Report
2025-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d938560d8k.htm   iXBRL 8-K 26777
2 EX-99.1 d938560dex991.htm EX-99.1 19256
3 EX-99.2 d938560dex992.htm EX-99.2 19791
7 GRAPHIC g938560ex99_2s10g1.jpg GRAPHIC 96537
8 GRAPHIC g938560ex99_2s11g1.jpg GRAPHIC 87300
9 GRAPHIC g938560ex99_2s12g1.jpg GRAPHIC 79242
10 GRAPHIC g938560ex99_2s13g1.jpg GRAPHIC 28636
11 GRAPHIC g938560ex99_2s14g1.jpg GRAPHIC 61581
12 GRAPHIC g938560ex99_2s1g1.jpg GRAPHIC 54006
13 GRAPHIC g938560ex99_2s2g1.jpg GRAPHIC 206983
14 GRAPHIC g938560ex99_2s3g1.jpg GRAPHIC 104354
15 GRAPHIC g938560ex99_2s4g1.jpg GRAPHIC 91336
16 GRAPHIC g938560ex99_2s5g1.jpg GRAPHIC 89918
17 GRAPHIC g938560ex99_2s6g1.jpg GRAPHIC 105613
18 GRAPHIC g938560ex99_2s7g1.jpg GRAPHIC 111030
19 GRAPHIC g938560ex99_2s8g1.jpg GRAPHIC 95227
20 GRAPHIC g938560ex99_2s9g1.jpg GRAPHIC 82816
21 GRAPHIC g938560g0520012304803.jpg GRAPHIC 2384
22 GRAPHIC g938560g0520020555046.jpg GRAPHIC 2721
  Complete submission text file 0001193125-25-122821.txt   1990169

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20250520.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20250520_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20250520_pre.xml EX-101.PRE 11265
33 EXTRACTED XBRL INSTANCE DOCUMENT d938560d8k_htm.xml XML 3670
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 25966148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)